Objetivo biológico (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Objetivo biológico" in Spanish language version.

refsWebsite

Global rank Spanish rank

14doi.org

2^nd place

12nih.gov

4^th place

1archive.org

6^th place

5^th place

archive.org

«Thermodynamic analysis of the drug-receptor interaction». Life Sciences 44 (4): 245-58. 1989. PMID 2536880. doi:10.1016/0024-3205(89)90182-3.

doi.org

dx.doi.org

«Thermodynamic analysis of the drug-receptor interaction». Life Sciences 44 (4): 245-58. 1989. PMID 2536880. doi:10.1016/0024-3205(89)90182-3.
«Intermolecular forces and energies between ligands and receptors». Science 266 (5183): 257-9. October 1994. PMID 7939660. doi:10.1126/science.7939660.
«How many drug targets are there?». Nature Reviews. Drug Discovery 5 (12): 993-6. December 2006. PMID 17139284. doi:10.1038/nrd2199.
«Drugs and their molecular targets: an updated overview». Fundamental & Clinical Pharmacology 22 (1): 1-18. February 2008. PMID 18251718. doi:10.1111/j.1472-8206.2007.00548.x.
An overview on GPCRs and drug discovery: structure-based drug design and structural biology on GPCRs 552. 2009. pp. 51-66. ISBN 978-1-60327-316-9. doi:10.1007/978-1-60327-317-6_4.
«Identifying druggable disease-modifying gene products». Current Opinion in Chemical Biology 13 (5–6): 549-55. December 2009. PMC 2787993. PMID 19740696. doi:10.1016/j.cbpa.2009.08.003.
«Opportunities and challenges in phenotypic drug discovery: an industry perspective». Nature Reviews. Drug Discovery 16 (8): 531-543. 2017. PMID 28685762. doi:10.1038/nrd.2017.111. «Novelty of target and MoA [Mechanism of Action] is the second major potential advantage of PDD [Phenotypic Drug Discovery]. In addition to identifying novel targets, PDD can contribute to improvements over existing therapies by identifying novel physiology for a known target, exploring ‘undrugged’ targets that belong to well known drug target classes or discovering novel MoAs, including new ways of interfering with difficult-to-drug targets.»
«Target identification for biologically active small molecules using chemical biology approaches». Archives of Pharmacal Research 39 (9): 1193-201. 2016. PMID 27387321. doi:10.1007/s12272-016-0791-z.
«Identification of direct protein targets of small molecules». ACS Chemical Biology 6 (1): 34-46. January 2011. PMC 3031183. PMID 21077692. doi:10.1021/cb100294v.
«Target deconvolution of bioactive small molecules: the heart of chemical biology and drug discovery». Archives of Pharmacal Research 38 (9): 1627-41. 2015. PMID 26040984. doi:10.1007/s12272-015-0618-3.
«Evolutionary conservation of human drug targets in organisms used for environmental risk assessments». Environmental Science & Technology 42 (15): 5807-5813. August 2008. PMID 18754513. doi:10.1021/es8005173.
«Ethinyloestradiol — an undesired fish contraceptive?». Aquatic Toxicology 45 (2–3): 91-97. April 1999. doi:10.1016/S0166-445X(98)00112-X.
«Repeating history: pharmaceuticals in the environment». Environmental Science & Technology 41 (24): 8211-7. 2007. PMID 18200843. doi:10.1021/es072658j.
«Risks to aquatic organisms posed by human pharmaceutical use». The Science of the Total Environment 389 (2–3): 329-39. 2008. PMID 17936335. doi:10.1016/j.scitotenv.2007.09.008.

nih.gov

ncbi.nlm.nih.gov

«Thermodynamic analysis of the drug-receptor interaction». Life Sciences 44 (4): 245-58. 1989. PMID 2536880. doi:10.1016/0024-3205(89)90182-3.
«Intermolecular forces and energies between ligands and receptors». Science 266 (5183): 257-9. October 1994. PMID 7939660. doi:10.1126/science.7939660.
«How many drug targets are there?». Nature Reviews. Drug Discovery 5 (12): 993-6. December 2006. PMID 17139284. doi:10.1038/nrd2199.
«Drugs and their molecular targets: an updated overview». Fundamental & Clinical Pharmacology 22 (1): 1-18. February 2008. PMID 18251718. doi:10.1111/j.1472-8206.2007.00548.x.
«Identifying druggable disease-modifying gene products». Current Opinion in Chemical Biology 13 (5–6): 549-55. December 2009. PMC 2787993. PMID 19740696. doi:10.1016/j.cbpa.2009.08.003.
«Opportunities and challenges in phenotypic drug discovery: an industry perspective». Nature Reviews. Drug Discovery 16 (8): 531-543. 2017. PMID 28685762. doi:10.1038/nrd.2017.111. «Novelty of target and MoA [Mechanism of Action] is the second major potential advantage of PDD [Phenotypic Drug Discovery]. In addition to identifying novel targets, PDD can contribute to improvements over existing therapies by identifying novel physiology for a known target, exploring ‘undrugged’ targets that belong to well known drug target classes or discovering novel MoAs, including new ways of interfering with difficult-to-drug targets.»
«Target identification for biologically active small molecules using chemical biology approaches». Archives of Pharmacal Research 39 (9): 1193-201. 2016. PMID 27387321. doi:10.1007/s12272-016-0791-z.
«Identification of direct protein targets of small molecules». ACS Chemical Biology 6 (1): 34-46. January 2011. PMC 3031183. PMID 21077692. doi:10.1021/cb100294v.
«Target deconvolution of bioactive small molecules: the heart of chemical biology and drug discovery». Archives of Pharmacal Research 38 (9): 1627-41. 2015. PMID 26040984. doi:10.1007/s12272-015-0618-3.
«Evolutionary conservation of human drug targets in organisms used for environmental risk assessments». Environmental Science & Technology 42 (15): 5807-5813. August 2008. PMID 18754513. doi:10.1021/es8005173.
«Repeating history: pharmaceuticals in the environment». Environmental Science & Technology 41 (24): 8211-7. 2007. PMID 18200843. doi:10.1021/es072658j.
«Risks to aquatic organisms posed by human pharmaceutical use». The Science of the Total Environment 389 (2–3): 329-39. 2008. PMID 17936335. doi:10.1016/j.scitotenv.2007.09.008.